Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-07, with 28 holding rows worth $656,081,000.

Accession
0001140361-17-041271
Filed
2017-11-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 28 entries on the cover page, a total value of $656,081,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $656,081,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM1,271,742$67,860,000thousands by filing date
Eli Lilly and Company532457108COM719,546$61,550,000thousands by filing date
BAXTER INTL INC071813109COM934,133$58,617,000thousands by filing date
Boston Scientific Corporation101137107COM1,468,880$42,847,000thousands by filing date
REVVITY INC714046109COM541,608$37,355,000thousands by filing date
Elevance Health, Inc.036752103COM182,610$34,674,000thousands by filing date
Bristol-Myers Squibb Company110122108COM459,606$29,295,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,825,002$28,780,000thousands by filing date
Gilead Sciences,Inc.375558103COM335,690$27,198,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW529,230$26,716,000thousands by filing date
BIOGEN INC COM09062X103Stock84,000$26,302,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR740,671$25,094,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO162,156$24,833,000thousands by filing date
BIO RAD LABS INC090572207CL A109,440$24,320,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock279,440$23,655,000thousands by filing date
MCKESSON CORP COM58155Q103Stock119,100$18,295,000thousands by filing date
PATTERSON COS INC703395103COM396,332$15,318,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM148,092$12,203,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW70,000$10,568,000thousands by filing date
NUVASIVE INC670704105COM183,000$10,149,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK737,453$9,063,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM422,261$8,572,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock515,180$8,464,000thousands by filing date
CIGNA CORPORATION125509109COM33,370$6,238,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM320,055$5,921,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR136,655$5,548,000thousands by filing date
ACCENDRA HEALTH INC690732102COM175,874$5,136,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW39,173$1,510,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-17-041271this filing2017-11-07acceptance time not in the bulk data set